Child and Adolescent Registry for Participants With Narcolepsy
Children, Adolescents and Their Providers: the Narcolepsy Assessment Partnership (CATNAPTM)
Jazz Pharmaceuticals
500 participants
Oct 10, 2020
OBSERVATIONAL
Conditions
Summary
CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed. The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.
Eligibility
Inclusion Criteria4
- Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
- Age less than 18 years
- Willing to participate in the Registry and complete the informed consent form
- Able to participate in English based registry
Exclusion Criteria2
- Age 18 years or more
- Fail to complete the informed consent form
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(25)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04899947